Pictet Investments

Pictet has invested in 9 companies and its latest investment was Generate Biomedicines on Sep 13, 2023

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Generate Biomedicines is a Massachusetts-based AI therapeutics platform that offers protein drug discovery solutions for the healthcare sector.
$273M
Sep 13, 2023
-
aMoon is a venture capital firm that focuses on investing in healthcare sector.
$340M
Jul 19, 2022
-
Unique is a Switzerland-based generative AI platform that offers solutions such as sales intelligence and customer engagement for sectors including banking and insurance.
$6.4M
Apr 10, 2022
-
Red Date is a China-based fintech firm that provides blockchain-based service network solutions for businesses.
$30M
Jun 09, 2021
-
BSN is a China-based blockchain platform that allows users to build and deploy scalable blockchain distributed applications.
$30M
Jun 08, 2021
-

Frequently Asked Questions about Pictet

  1. What is Pictet investing in?

    Pictet has invested in 9 companies including Generate Biomedicines, aMoon and Unique
  2. What company did Pictet invest in?

    Pictet invested in a total 9 companies including Generate Biomedicines, aMoon and Unique
  1. What are the top 5 investments by Pictet?

    The top companies in which Pictet invested are Generate Biomedicines, aMoon, Unique, Red Date and BSN